Informations sur le produit
Nom :
AZD-9291
Synonymes :
- [u'AZD9291', u'osimertinib', u'1421373-65-0', u'AZD9291', u'Mereletinib', u'Tagrisso', u'UNII-3C06JJ0Z2O', u'3C06JJ0Z2O', u'N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide', u'N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide', u'AK170511', u'N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide', u'N-(2-{[2-(Dimethylamino)ethyl](Methyl)amino}-4-Methoxy-5-{[4-(1-Methyl-1h-Indol-3-Yl)pyrimidin-2-Yl]amino}phenyl)prop-2-Enamide', u'Mereletinib [INN]', u'Osimertinib [USAN]', u'osimertinibum', u'N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide', u'Tube720', u'Osimertinib (AZD9291)', u'mereletinib (obsolete INN)', u'GTPL7719', u'CHEMBL3353410', u'SCHEMBL14660911', u'CHEBI:90943', u'AOB6268', u'EX-A314', u'DUYJMQONPNNFPI-UHFFFAOYSA-N', u'C28H33N7O2', u'HMS3653E10', u'BCP08626', u'KS-000007ZW', u'ABP001123', u'BDBM50029668', u'MFCD27988062', u's7297', u'ZINC98023177', u'AKOS025290756', u'CS-2018', u'DB09330', u'SB22952', u'NCGC00378622-10', u'2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-', u'4CA-0243', u'AC-29019', u'AS-16943', u'HY-15772', u'QC-11454', u'SC-94470', u'FT-0696828', u'SW219863-1', u'X3507', u'Mereletinib pound AZD-9291 Osimertinib pound(c)', u'N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)acrylamide', u'N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide', u'N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide', u'osimertinib mesilate', u'Osimertinib mesylate', u'AZD9291 mesylate', u'D0RT2C', u'Tyrosine Kinase Inhibitor - Ns', u'C28-H33-N7-O2', u'ACN-031533', u'B1104', u'A13681', u'Osimertinib, 98%, a potent and selective mutated forms EGFR inhibitor - 25MG 25mg', u'2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-', u'N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide.']
- 2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
- Azd9291
- Mereletinib
- N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide
- Osimertinib
- Tagrisso
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
499.6073
Formule :
C28H33N7O2
Degré de pureté :
99%
Couleur/Forme :
Solid
InChI :
InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)
Code InChI :
DUYJMQONPNNFPI-UHFFFAOYSA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
